Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2026-02-20 @ 10:08 PM
Study NCT ID:
NCT02204761
Status:
COMPLETED
Last Update Posted:
2018-11-20
First Post:
2014-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Proton Beam Re-Irradiation in Thoracic Cancers
Sponsor:
University of Washington
Organization:
Study Overview
Official Title:
Definitive Re-irradiation With Proton Beam Radiotherapy for Patients With Recurrent Thoracic Cancers
Status:
COMPLETED
Status Verified Date:
2018-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This pilot clinical trial studies proton beam radiation therapy in treating patients with thoracic cancer that has come back and have received prior radiation therapy. Proton beam radiation therapy uses high energy protons to kill tumor cells and may cause less damage to normal tissue.
Detailed Description:
PRIMARY OBJECTIVES:
I. To assess the grade 3 toxicity associated with thoracic re-irradiation with proton therapy, with prospectively applied normal organ radiation dose limits.
SECONDARY OBJECTIVES:
I. To assess the efficacy of thoracic re-irradiation with proton therapy.
OUTLINE:
Patients undergo proton beam radiation therapy per standard of care.
After completion of study treatment, patients are followed up at 3 months.
I. To assess the grade 3 toxicity associated with thoracic re-irradiation with proton therapy, with prospectively applied normal organ radiation dose limits.
SECONDARY OBJECTIVES:
I. To assess the efficacy of thoracic re-irradiation with proton therapy.
OUTLINE:
Patients undergo proton beam radiation therapy per standard of care.
After completion of study treatment, patients are followed up at 3 months.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| NCI-2014-01468 | REGISTRY | CTRP (Clinical Trial Reporting Program) | View | |
| 9148 | OTHER | University of Washington | View | |
| P30CA015704 | NIH | None | https://reporter.nih.gov/quic… | View |